Cart
sales@molnova.com
SLF-amido-C2-COOH
CAS No. 1092369-24-8
SLF-amido-C2-COOH( —— )
Catalog No. M33238 CAS No. 1092369-24-8
SLF-amido-C2-COOH (ZZY01-083) is an FKBP ligand with potential antimicrobial activity for the synthesis of PROTAC.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 99 | In Stock |
|
| 5MG | 149 | In Stock |
|
| 10MG | 254 | In Stock |
|
| 25MG | 546 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSLF-amido-C2-COOH
-
NoteResearch use only, not for human use.
-
Brief DescriptionSLF-amido-C2-COOH (ZZY01-083) is an FKBP ligand with potential antimicrobial activity for the synthesis of PROTAC.
-
DescriptionSLF-amido-C2-COOH (PROTAC FKBP12-binding moiety 1) is a synthetic ligand for FKBP (SLF). SLF-amido-C2-COOH (PROTAC FKBP12-binding moiety 1) can be used in the synthesis of PROTACs.
-
In VitroSLF-amido-C2-COOH (PROTAC FKBP12-binding moiety 1) is a synthetic ligand for FKBP (SLF). SLF is composed of only one half of FK506 and it is known to have a significantly weaker affinity for FKBP12.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorLigands for Target Protein for PROTAC | FKBP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1092369-24-8
-
Formula Weight624.72
-
Molecular FormulaC34H44N2O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (160.07 mM; Ultrasonic )
-
SMILES[C@@H](OC(=O)[C@H]1N(C(C(C(CC)(C)C)=O)=O)CCCC1)(CCC2=CC(OC)=C(OC)C=C2)C3=CC(NC(CCC(O)=O)=O)=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dunyak BM, et al. Selective Targeting of Cells via Bispecific Molecules That Exploit Coexpression of TwoIntracellular Proteins. ACS Chem Biol. 2015 Nov 20;10(11):2441-7.?
molnova catalog
related products
-
LEM-14-1189 B
Lem-14-1189, a LEM-14 derivative, is a potent NSD inhibitor of the nuclear receptor binding SET domain, and has inhibitory effects on NSD1, NSD2, and NSD3, with IC50 of 418 μM, 111 μM, and 60 μM, respectively.
-
trans-2-Butene-14-di...
3-Hexenedioic acid is a normal human unsaturated dicarboxylic acid metabolite with increased excretion in patients with Dicarboxylic aciduria caused by fatty acid metabolism disorders The urinary excretion of 3-Hexenedioic acid is increased in conditions of augmented mobilization of fatty acids or inhibited fatty acid oxidation.
-
BIM-46187 4HCl
PH-064 4HCl is a heterotrimeric G-protein complex inhibitor.
